NextCure (NXTC) Earnings Date, Estimates & Call Transcripts $0.45 -0.01 (-1.23%) Closing price 07/9/2025 04:00 PM EasternExtended Trading$0.46 +0.01 (+2.44%) As of 07/9/2025 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NextCure Earnings Summary NextCure released Q1 2025 earnings on May 1, 2025, reporting an EPS of -$0.39, which beat analysts' consensus estimates of -$0.40 by $0.01. With a trailing EPS of -$1.76, NextCure's earnings are expected to grow next year, from ($1.87) to ($1.44) per share. Upcoming Q2 Earnings DateJul. 30Before Market OpensEstimatedConsensus EPS (May. 1) -$0.40 Actual EPS (May. 1) -$0.39 Beat By $0.01 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)NXTC Upcoming EarningsNextCure's next earnings date is estimated for Wednesday, July 30, 2025, based on past reporting schedules. Powered by Get NextCure Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NextCure and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNXTC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. NextCure Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($1.87) EPSNext Year EPS Consensus Estimate ($1.44) EPS NextCure Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/30/2025(Estimated)--------5/1/2025Q1 2025-$0.40-$0.39+$0.01-$0.39--3/6/2025Q4 2024-$0.34-$0.41 -$0.07-$0.41--11/7/2024--$0.35-$0.41 -$0.06-$0.41--8/1/2024--$0.36-$0.55 -$0.19-$0.55--5/2/2024Q1 2024-$0.45-$0.61 -$0.16-$0.61--3/21/2024Q4 2023-$0.54-$0.52+$0.02-$0.52--11/2/2023Q3 2023-$0.64-$0.51+$0.13-$0.51--8/3/2023Q2 2023-$0.60-$0.64 -$0.04-$0.64-- NextCure Earnings - Frequently Asked Questions When is NextCure's earnings date? NextCure has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 30th, 2025 based off last year's report dates. Learn more on NXTC's earnings history. Did NextCure beat their earnings estimates last quarter? In the previous quarter, NextCure (NASDAQ:NXTC) reported ($0.39) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.40) by $0.01. Learn more on analysts' earnings estimate vs. NXTC's actual earnings. How much profit does NextCure generate each year? NextCure (NASDAQ:NXTC) has a recorded net income of -$55.65 million. NXTC has generated -$1.76 earnings per share over the last four quarters. What is NextCure's EPS forecast for next year? NextCure's earnings are expected to grow from ($1.87) per share to ($1.44) per share in the next year. More Earnings Resources from MarketBeat Related Companies Renovaro Earnings bluebird bio Earnings Adverum Biotechnologies Earnings Verrica Pharmaceuticals Earnings Precision BioSciences Earnings Aadi Bioscience Earnings Atara Biotherapeutics Earnings RenovoRx Earnings vTv Therapeutics Earnings Applied Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:NXTC) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NextCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NextCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NXTC Stock Alerts